Relmada Therapeutics, Inc.

NASDAQ:RLMD

Biotechnology

Healthcare
$3.11 -0.97%

-$0.06 today

Market cap
$331.82M
Beta
0.39
P/E (TTM)
-9.6
EPS (TTM)
-$0.68
52W Low $0.52High $8.00

Volume 1.71M

Average 1.24M

Price history

Relmada Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-28.01%

Period high

$7.86

Period low

$2.86

Latest

$3.11

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
10-QNov 12, 2026Nov 12, 2026
8-KNov 12, 2026Nov 12, 2026
4Sep 11, 2026Sep 11, 2026
4Sep 11, 2026Sep 11, 2026
8-KSep 8, 2026Sep 8, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
8-KAug 6, 2026Aug 6, 2026
10-QAug 6, 2026Aug 6, 2026
SC 13GJul 29, 2026Jul 29, 2026
8-KJul 28, 2026Jul 28, 2026
SC 13GJun 22, 2026Jun 22, 2026
S-8Jun 18, 2026Jun 18, 2026
SC 13GJun 9, 2026Jun 9, 2026
8-KMay 28, 2026May 28, 2026
S-3ASRMay 13, 2026May 13, 2026

Competitors

Who does Relmada Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about RLMD's filings, answered from its disclosures.

What is the latest RLMD filing?

The latest filing shown is 10-Q dated Nov 12, 2026.

How many recent filings does RLMD have?

Intrinsic Alpha currently shows 20 recent filings for RLMD.